Should routine serological screening for HCV be mandatory in HIV/AIDS patients enrolling for HAART in South Africa?

South African Medical Journal

Volumn 100, Issue 12, 2010, Pages 814-815

  Gededzha, Maemu P ^a   Mphahlele, M Jeffrey ^a   Lukhwareni, Azwidowi ^a   Selabe, Selokela G ^a  

^a NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; CLINICAL ARTICLE; FEMALE; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MALE; MIXED INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCREENING; SEROPREVALENCE; SOUTH AFRICA;

EID: 78650086752     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: 10.7196/samj.4238     Document Type: Letter

References (17)

1. Sulkowski MS, Mast EE, Seeff LB, Thomas DL. Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus. Clin Infect Dis 2000;30(1):s77-s84.
2. Soni PN, Tait DR, Kenoyer DG, et al. Hepatitis C virus antibodies among risk groups in a South African area endemic for hepatitis B virus. J Med Virol 1993;40(1):65-68.
3. Basetse H, Peenze I, Aspinall S. Hepatitis C virus antibodies in the black population of Garankuwa. SMLTSA 1993;6(5):88-89.
4. Ellis L, Brown D, Conradie J, et al. Prevalence of hepatitis C in South Africa: detection of anti-HCV in recent and stored serum. J Med Virol 1990;32(4):249-251.
5. Vardas E, Ross M, Sharp G, McAnerney J, Sim J. Viral hepatitis in South African healthcare workers at increased risk of occupational exposure to blood-borne viruses. J Hosp Infect 2002;50:6-12.
6. Alter M. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 2006;44:S6-S9.
7. Newcomb-Fernandez J. Co-infection with HIV and hepatitis C: An overview. RITA 2004;10(2):5-16.
8. Miller MF, Haley C, Koziel MJ, Rowley CF. Impact of hepatitis C virus on immune restoration in HIV-infected patients who start highly active antiretroviral therapy: a meta-analysis. Clin Infect Dis 2005;41(5):713-720.
9. Sulkowski MS, Thomas DL, Chaisson RE, Moore RD. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. J Am Med Assoc 2000;283(1):74-80.
10. Lukhwareni A, Burnett RJ, Selabe SG, Mzileni MO, Mphahlele MJ. Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a tertiary hospital. J Med Virol 2009;81(3):406-412.
11. Amin J, Kaye M, Skidmore S, Pillay D, Cooper DA, Dore GJ. HIV and hepatitis C co-infection within CAESAR study. HIV Medicine 2004;5(3):174-179.
12. Parboosing R, Paruk I, Lalloo UG. Hepatitis C virus seropositivity in a South African cohort of HIV co-infected, ARV naive patients is associated with renal insufficiency and increased mortality. J Med Virol 2008;80:1530-1536.
13. Sithebe NP, Aspinall S, Smuts H. Molecular epidemiology of hepatitis C virus infection at Garankuwa hospital. S Afr Med J 1996;86(12):1543-1545.
14. South African department of health. 2008 National Antenatal Sentinel HIV & Syphilis Prevalence Survey. http://www.doh.gov.za/docs/reports/2009/nassps/index.html (accessed 17 March 2010).
15. Ndong-Atome G, Makuwa M, Njouom R, et al. Hepatitis C virus prevalence and genetic diversity among pregnant women in Gabon, central Africa. BMC Infect Dis 2008;8(82):1471-2334.
16. Kohara M, Stuver S, Tsubouchi H. Spontaneous elimination of hepatitis C virus RNA in individuals with persistent infection in a hyperendemic area of Japan. Hepatol Res 2006;34(1):28-34.
17. Sorbi D, Shen D, Lake-Bakaar G. Influence of HIV disease on serum anti-HCV antibody titers: a study of intravenous drug users. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13:295-296.